ZA200802876B - Novel use of IL-1beta compounds - Google Patents

Novel use of IL-1beta compounds

Info

Publication number
ZA200802876B
ZA200802876B ZA200802876A ZA200802876A ZA200802876B ZA 200802876 B ZA200802876 B ZA 200802876B ZA 200802876 A ZA200802876 A ZA 200802876A ZA 200802876 A ZA200802876 A ZA 200802876A ZA 200802876 B ZA200802876 B ZA 200802876B
Authority
ZA
South Africa
Prior art keywords
novel use
1beta compounds
1beta
compounds
novel
Prior art date
Application number
ZA200802876A
Inventor
Lowe Phil
Gram Hermann
Jung Thomas
Wright Timothy
Mundel Trevor
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200802876B publication Critical patent/ZA200802876B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/246—IL-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200802876A 2005-10-26 2008-04-02 Novel use of IL-1beta compounds ZA200802876B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73043505P 2005-10-26 2005-10-26

Publications (1)

Publication Number Publication Date
ZA200802876B true ZA200802876B (en) 2009-09-30

Family

ID=40035589

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200802876A ZA200802876B (en) 2005-10-26 2008-04-02 Novel use of IL-1beta compounds

Country Status (2)

Country Link
NO (1) NO20211027A1 (en)
ZA (1) ZA200802876B (en)

Also Published As

Publication number Publication date
NO20211027A1 (en) 2008-07-22

Similar Documents

Publication Publication Date Title
IL277406A (en) Novel use of il-1beta compounds
PL2335782T3 (en) Use of compositions comprising HFCO-1233zd
GB0509326D0 (en) Therapeutic compounds
GB0509573D0 (en) Therapeutic compounds
GB0509405D0 (en) Therapeutic compounds
EP1863473A4 (en) Novel use of lignan compounds
GB0505954D0 (en) Novel use
EP1888618A4 (en) Analogs of glycyl-prolyl-glutamate
GB0513747D0 (en) Therapeutic compounds
HK1161122A1 (en) Use of 24-norudca 24-norudca
EP1938808A4 (en) Preparation for external use
GB0518235D0 (en) Therapeutic compounds
GB0506001D0 (en) Novel use
EP1827449A4 (en) The use of novel antibacterial compounds
EP1931370A4 (en) Use of des-aspartate-angiotensin i
EP1846443A4 (en) Novel use
ZA200802876B (en) Novel use of IL-1beta compounds
GB0515580D0 (en) Therapeutic compounds
GB0526295D0 (en) Novel therapeutic compounds
GB0512574D0 (en) Uses of (s)-clenbuterol
GB0525456D0 (en) Novel use
GB0521273D0 (en) Novel use
GB0615597D0 (en) Novel use
GB0516650D0 (en) Novel use
GB0505955D0 (en) Novel use